^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    TmMSTN-01

    i
    Other names: TmMSTN-01, anti-MSLN CAR T cell therapy, huCART-meso
    Associations
    News
    Trials
    Company:
    Gilead, University of Pennsylvania
    Drug class:
    Mesothelin-targeted CAR-T immunotherapy
    Related drugs:
    Associations
    News
    Trials